Indoco Remedies Share Price Today | Stock Price & Indoco Remedies Share Screener
As of October 5, 2026, the live Indoco Remedies share price (NSE: INDOCO) is ₹246.80 on NSE and ₹247.00 on BSE, down 1.97% from the previous close, with shares trading between ₹244.10 and ₹255.65 in today's trading session, and a 52-week range of ₹164.00–₹282.20. Check Indoco Remedies 52-week for the annual price range and momentum. Use the Indoco Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Indoco Remedies opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹566 and net income of ₹65, with EBITDA of ₹139, an operating margin of 9.0% and a profit margin of 11.5%.
Indoco Remedies Share Price Chart
Track the current stock price of Indoco Remedies with an interactive chart. Analyse INDOCO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Indoco Remedies stock quote in one place.
The quote of ₹246.80 sits between the 52-week low of ₹164.00 and the 52-week high of ₹282.20, and the latest session moved -1.97% from the previous close.
Indoco Remedies Company Profile - Fundamental Screener
Screen Indoco Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDOCO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE873D01024.
Company Details
Classification
Identifiers and Leadership
Indoco Remedies Balance Sheet Screener
Screen INDOCO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹2,593, up from ₹2,430 in 2025.
Latest statistics put total assets at ₹2,593 and shareholder funds at ₹932, with a leverage ratio of 1.06.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 2,593 | 2,430 | 2,145 | 1,658 | 1,486 | 1,315 | 1,272 | 1,258 | 1,236 | 1,197 |
| Current Assets | 1,193 | 1,001 | 955 | 814 | 774 | 623 | 563 | 538 | 537 | 572 |
| Fixed Assets | 1,193 | 997 | 954 | 678 | 555 | 570 | 590 | 468 | 489 | 440 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 609 | 604 | 422 | 205 | 157 | 139 | 133 | 152 | 146 | 155 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 932 | 1,018 | 1,111 | 1,028 | 905 | 769 | 680 | 661 | 675 | 651 |
| Share Capital | 19 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves & Surplus | 921 | 1,004 | 1,092 | 1,010 | 886 | 751 | 661 | 642 | 657 | 633 |
Indoco Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Indoco Remedies income statement and profit fundamentals. Analyze INDOCO quarterly results. Indoco Remedies reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹566 and net profit was ₹65, equal to earnings per unit of ₹7.09, at an operating margin of 9%.
In that period expenses were ₹427, interest cost ₹28 and tax ₹12. The next period listed, 2026-Mar, shows revenue of ₹460 and net profit of ₹-24.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 566 | 460 | 435 | 473 | 433 | 386 | 404 | 432 | 425 | 462 | 461 | 478 | 417 | 429 | 412 |
| Expenses | 427 | 426 | 420 | 442 | 422 | 391 | 399 | 392 | 384 | 401 | 405 | 410 | 365 | 363 | 337 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 139 | 34 | 15 | 30 | 10 | -5 | 6 | 40 | 42 | 61 | 56 | 68 | 52 | 66 | 74 |
| Operating Profit % | 9.00% | 7.00% | 3.00% | 6.00% | 2.00% | -2.00% | 1.00% | 9.00% | 10.00% | 9.00% | 12.00% | 13.00% | 12.00% | 15.00% | 18.00% |
| Depreciation | 35 | 33 | 32 | 32 | 30 | 29 | 29 | 29 | 28 | 26 | 24 | 21 | 20 | 18 | 17 |
| Interest | 28 | 46 | 26 | 25 | 26 | 18 | 16 | 18 | 14 | 12 | 10 | 8 | 8 | 9 | 7 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 78 | -25 | -31 | -14 | -37 | -46 | -31 | -5 | 7 | 33 | 23 | 46 | 34 | 39 | 38 |
| Tax | 12 | -1 | -2 | -4 | 0 | -4 | -3 | 5 | 5 | 11 | 7 | 11 | 10 | 13 | 10 |
| Net Profit | 65 | -24 | -30 | -9 | -36 | -41 | -28 | -10 | 2 | 22 | 16 | 35 | 24 | 26 | 28 |
| EPS | 7.09 | -2.57 | -3.20 | -1.00 | -3.94 | -4.48 | -3.08 | -1.09 | 0.20 | 2.39 | 1.69 | 3.82 | 2.62 | 2.80 | 3.05 |
Indoco Remedies Cash Flow Screener - Liquidity Fundamentals
Screen INDOCO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹192, and net cash flow was an inflow of ₹14.
Over the same period, investing activities used ₹102 and financing activities used ₹77.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 192 | 95 | 157 | 179 | 174 | 82 | 123 | 132 | 123 | 89 |
| Investing Activities | -102 | -339 | -433 | -208 | -121 | -67 | -56 | -104 | -135 | -171 |
Financing and Net Cash | ||||||||||
| Financing Activities | -77 | 241 | 280 | 23 | -44 | -30 | -64 | -16 | -39 | 132 |
| Net Cash Flow | 14 | -3 | 4 | -7 | 8 | -14 | 3 | 12 | -52 | 50 |
Indoco Remedies Shareholding Pattern Screener
See Indoco Remedies shareholding pattern with promoter, FII, and DII holdings. Check Indoco Remedies promoter holding and ownership changes for INDOCO on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 58.86%, foreign institutions 0.94%, domestic institutions 18.15% and the public 16.56%, spread across 32,276 shareholders.
The shareholder count was 32,276 in 2026-Mar, compared with 32,457 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 58.86% | 58.86% | 58.90% | 58.90% | 58.90% | 58.90% | 58.72% | 58.75% |
Institutional Investors | ||||||||
| FII Holding | 0.94% | 1.27% | 1.24% | 1.22% | 1.25% | 1.10% | 1.91% | 1.47% |
| DII Holding | 18.15% | 17.68% | 18.75% | 18.96% | 18.16% | 18.15% | 19.41% | 18.67% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.56% | 16.68% | 15.99% | 15.79% | 16.40% | 16.48% | 15.33% | 16.29% |
| Other Holding | 5.48% | 5.50% | 5.12% | 5.14% | 5.29% | 5.38% | 4.62% | 4.81% |
| Shareholder Count | 32,276 | 32,457 | 34,497 | 33,129 | 33,319 | 32,659 | 33,201 | 34,511 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Indoco Remedies. Indoco Remedies dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.20 per unit for 2026-March, a yield of 0.08%, compared with ₹0.20 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.20, ₹0.20 and ₹1.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.20 | 0.08% |
| 2025-March | ₹0.20 | 0.12% |
| 2024-March | ₹1.50 | 0.64% |
| 2023-March | ₹2.25 | 0.68% |
| 2022-March | ₹2.25 | 0.69% |
| 2021-March | ₹1.50 | 0.40% |
| 2020-March | ₹0.30 | 0.10% |
| 2019-March | ₹0.30 | 0.14% |
| 2018-March | ₹1.00 | 0.49% |
| 2017-March | ₹1.60 | 0.75% |
Indoco Remedies Stock Index Membership - Nifty & Sensex
See which indices include Indoco Remedies stock. Check INDOCO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 3 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.
Complete Index List
Indoco Remedies Market Events Screener - Corporate Actions
Get Indoco Remedies corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Indoco Remedies stock events that may affect INDOCO share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 17, 2026, with a record date of September 17, 2026.
It is followed by Dividend dated September 10, 2026 and Quarterly Result Announcement dated July 28, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-17 | 2026-09-17 | Annual General Meeting | NA | 14.56% |
| 2026-09-10 | 2026-09-10 | Dividend | ₹ 0.20 /share | 1.43% |
| 2026-07-28 | 2026-07-28 | Quarterly Result Announcement | NA | -0.31% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 10.47% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | 0.46% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -7.97% |
| 2025-09-11 | 2025-09-11 | Annual General Meeting | NA | -5.74% |
| 2025-09-04 | 2025-09-04 | Dividend | ₹ 0.20 /share | 8.04% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | -4.86% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 4.17% |
| 2025-01-21 | 2025-01-21 | Quarterly Result Announcement | NA | 2.60% |
| 2024-10-24 | 2024-10-24 | Quarterly Result Announcement | NA | -4.96% |
| 2024-09-26 | 2024-09-26 | Annual General Meeting | NA | 0.00% |
| 2024-09-19 | 2024-09-19 | Dividend | ₹ 1.50 /share | 12.85% |
| 2023-09-18 | 2023-09-19 | Dividend | ₹ 2.25 /share | 2.59% |
Indoco Remedies Competitors Screener - Peer Stocks Comparison
Screen INDOCO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,010 | 35.84 | 61,674 | 12.69% | 11,565 | 33.78 |
| Divis Laboratories | 244,125 | 84.36 | 11,067 | 13.95% | 2,568 | 49.73 |
| Torrent Pharmaceuticals | 181,512 | 84.01 | 13,886 | 20.34% | 2,138 | 41.48 |
| Zydus Life Science | 113,616 | 24.88 | 27,658 | 17.64% | 5,026 | 46.18 |
| Cipla | 107,890 | 32.42 | 29,045 | 2.24% | 3,870 | 32.87 |
| Laurus Labs | 106,517 | 98.56 | 6,868 | 22.01% | 890 | 56.11 |
| Mankind Pharma | 102,394 | 50.48 | 14,636 | 14.85% | 1,938 | 55.53 |
| Dr Reddys Laboratories | 100,412 | 31.47 | 35,059 | 3.90% | 4,158 | 52.91 |
| Aurobindo Pharma | 96,370 | 25.97 | 34,145 | 5.56% | 3,503 | 49.89 |
| Lupin | 91,961 | 16.71 | 29,039 | 26.75% | 5,356 | 29.12 |
Indoco Remedies Company Announcements - News & Reports Screener
Screen INDOCO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 30, 2026.
The next most recent announcements are dated September 29, 2026 and September 29, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-30 | Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN KYC And Bank Details As Per SEBI Master Circular No. HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 Dated February 6 2026 | - |
| 2026-09-29 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-09-29 | Closure of Trading Window | - |
| 2026-09-24 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating | - |
| 2026-09-18 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-09-18 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-17 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-10 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations2015 | - |
| 2026-09-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-05 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations2015 | - |
| 2026-09-03 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-01 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-08-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-21 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-21 | Reg. 34 (1) Annual Report. | - |
| 2026-08-21 | Notice Of 79Th Annual General Meeting And Annual Report For The Financial Year 2025-2026 | - |
| 2026-08-21 | Notice Of 79Th Annual General Meeting And Annual Report For The Financial Year 2025-2026 | - |
| 2026-08-21 | Intimation Of Cut-Off Date For E-Voting Book Closure And Record Date For Dividend | - |
| 2026-08-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹246.80, within a 52-week range of ₹164.00 to ₹282.20. The P/E ratio is 740.29 and the P/B ratio is 2.47, with earnings per unit of ₹-10.70. Market capitalisation stands at ₹2,278.05 Cr and the dividend yield is 0.08%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.